MEDICINAL CHEMISTRY OF GINKGOLIDES FROM GINKGO BILOBA - Medicinal Chemistry of Bioactive Natural Products - page 320

77. Kato, K.; Clark, G. D.; Bazan, N. G.; Zorumski, C. F. Platelet-activating factor as a
potential retrograde messenger in CA1 hippocampal long-term potentiation. Nature,
1994, 367: 175-179.
78. Kornecki, E.; Wieraszko, A.; Chan, J. C.; Ehrlich, Y. H. Platelet activating factor (PAF)
in memory formation: Role as a retrograde messenger in long-term potentiation. J. Lipid
Mediators Cell Signal., 1996, 14: 115-126.
79. Izquierdo, I.; Fin, C.; Schmitz, P. K.; Da Silva, R. C.; Jerusalinsky, D.; Quillfeldt, J. A.;
Ferreira, M. B.; Medina, J. H.; Bazan, N. G. Memory enhancement by intrahippocampal,
intraamygdala, or intraentorhinal infusion of platelet-activating factor measured in an
inhibitory avoidance task. Proc. Natl. Acad. Sci. USA, 1995, 92: 5047-5051.
80. Kato, K. Modulation of long-term potentiation in the CA1 area of rat hippocampus by
platelet-activiting factor. Adv. Exp. Med. Biol., 1999, 469: 221-227.
81. Bito, H.; Nakamura, M.; Honda, Z.; Izumi, T.; Iwatsubo, T.; Seyama, Y.; Ogura, A.;
Kudo, Y.; Shimizu, T. Platelet-activating factor (PAF) receptor in rat brain: PAF
mobilizes intracelluar Ca 2 þ in hippocampal neurones. Neuron, 1992, 9: 285-294.
82. Bazan, N. G.; Allan, G. Platelet-activating factor in the modulation of excitatory amino
acid neurotransmitter release and of gene expression. J. Lipid Mediators Cell Signal.,
1996, 14: 321-330.
83. Dell' Albani, P.; Condorelli, D. F.; Mudo, G.; Amico, C.; Bindoni, M.; Belluardo, N.
Platelet-activating factor and its methoxy-analogue ET-18-OCH 3 stimulate immediate
early gene expression in rat astroglial cultures. Neurochem. Int., 1993, 22: 567-
574.
84. Doucet, J. P.; Bazan, N. G. Excitable membranes, lipid messengers, and immediate-early
genes. Alteration of signal transduction in neuromodulation and neurotrauma. Mol.
Neurobiol., 1992, 6: 407-424.
85. Kobayashi, K.; Ishii, S.; Kume, K.; Takahashi, T.; Shimizu, T.; Manabe, T. Platelet-
activating factor receptor is not required for long-term potentiation in the hippocampal
CA1 region. Eur. J. Neurosci., 1999, 11: 1313-1316.
86. Chen, C.; Magee, J. C.; Marcheselli, V.; Hardy, M.; Bazan, N. G. Attenuated LTP in
hippocampal dentate gyrus neurons of mice deficient in the PAF receptor. J. Neuro-
physiol., 2001, 85: 384-390.
87. Kondratskaya, E. L.; Pankratov, Y. V.; Lalo, U. V.; Chatterjee, S. S.; Krishtal, O. A.
Inhibition of hippocampal LTP by ginkgolide B is mediated by its blocking action on
PAF rather than glycine receptors. Neurochem. Int., 2004, 44: 171-177.
88. Braquet, P.; Spinnewyn, B.; Braquet, M.; Bourgain, R. H.; Taylor, J. E.; Etienne, A.;
Drieu, K. BN 52021 and related compounds: a new series of highly specific PAF-acether
antagonists isolated from Ginkgo biloba L. Blood Vessels, 1985, 16: 558-572.
89. Braquet, P.; Esan, A. Ginkgolide derivatives. U.K. Patent 2,211,841, 1989.
90. Corey, E. J.; Gavai, A. V. Simple analogs of ginkgolide-B which are highly-active
antagonists of platelet activating factor. Tetrahedron Lett., 1989, 30: 6959-6962.
91. Corey, E. J.; Rao, K. S. Enantioselective total synthesis of ginkgolide derivatives lacking
the tert-butyl group, an essential structural subunit for antagonism of platelet activating
factor. Tetrahedron Lett., 1991, 32: 4623-4626.
92. Villhauer, E. B.; Anderson, R. C. Synthesis of the CDE ring system of the ginkgolides.
J. Org. Chem., 1987, 52: 1186-1189.